First Trust Advisors’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.2M | Sell |
2,601,808
-154,147
| -6% | -$2.38M | 0.03% | 651 |
|
|
2025
Q1 | $41M | Sell |
2,755,955
-484,977
| -15% | -$7.21M | 0.04% | 621 |
|
|
2024
Q4 | $42.9M | Buy |
3,240,932
+62,718
| +2% | +$830K | 0.04% | 596 |
|
|
2024
Q3 | $45.2M | Buy |
+3,178,214
| New | +$45.2M | 0.04% | 536 |
|
|
2023
Q4 | – | Sell |
-233,119
| Closed | -$3.61M | – | 2433 |
|
|
2023
Q3 | $3.61M | Buy |
233,119
+68,066
| +41% | +$1.05M | ﹤0.01% | 1407 |
|
|
2023
Q2 | $2.59M | Sell |
165,053
-243,710
| -60% | -$3.83M | ﹤0.01% | 1577 |
|
|
2023
Q1 | $6.74M | Buy |
408,763
+179,939
| +79% | +$2.97M | 0.01% | 1106 |
|
|
2022
Q4 | $3.57M | Sell |
228,824
-54,875
| -19% | -$856K | ﹤0.01% | 1399 |
|
|
2022
Q3 | $3.68M | Sell |
283,699
-46,594
| -14% | -$604K | ﹤0.01% | 1355 |
|
|
2022
Q2 | $4.64M | Sell |
330,293
-457,665
| -58% | -$6.43M | 0.01% | 1265 |
|
|
2022
Q1 | $11.3M | Sell |
787,958
-47,098
| -6% | -$674K | 0.01% | 1012 |
|
|
2021
Q4 | $11.4M | Sell |
835,056
-1,045,939
| -56% | -$14.3M | 0.01% | 1009 |
|
|
2021
Q3 | $30.8M | Buy |
1,880,995
+336,324
| +22% | +$5.51M | 0.03% | 623 |
|
|
2021
Q2 | $26M | Sell |
1,544,671
-315,586
| -17% | -$5.31M | 0.03% | 668 |
|
|
2021
Q1 | $34M | Buy |
+1,860,257
| New | +$34M | 0.04% | 529 |
|
|
2020
Q3 | – | Sell |
-1,396,270
| Closed | -$25M | – | 2473 |
|
|
2020
Q2 | $25M | Sell |
1,396,270
-43,557
| -3% | -$781K | 0.04% | 495 |
|
|
2020
Q1 | $21.9M | Sell |
1,439,827
-588,092
| -29% | -$8.93M | 0.05% | 477 |
|
|
2019
Q4 | $40M | Sell |
2,027,919
-13,214
| -0.6% | -$261K | 0.07% | 436 |
|
|
2019
Q3 | $35.1M | Buy |
2,041,133
+385,573
| +23% | +$6.63M | 0.07% | 432 |
|
|
2019
Q2 | $29.3M | Sell |
1,655,560
-967,723
| -37% | -$17.1M | 0.06% | 450 |
|
|
2019
Q1 | $53.4M | Buy |
+2,623,283
| New | +$53.4M | 0.11% | 237 |
|